Skip to content

A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry Skin

A Bilateral, Controlled Clinical Trial to Evaluate 2 Different Moisturizer Chassis Formulas for the Relief of Dry Skin

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04510103
Enrollment
46
Registered
2020-08-12
Start date
2015-10-23
Completion date
2016-04-07
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin, Skin Care, Skin Cream

Keywords

Skin, Stratum Corneum, Skin Care, Skin Cream, Dryness, Moisturization, Hydration

Brief summary

Dry skin is characterized by a lack of moisture in the outer layer of the skin and can occur as a result of numerous factors including cold weather, low humidity, age, etc. In this study, the moisturizing benefits of two formulas were evaluated for barrier function improvement/impact when used by women with moderately to severely dry skin on their lower legs.

Interventions

DRUGMoisturizer A, F#9155-005

OTC Monograph Drug. Used twice daily on left or right lower leg per randomization schedule.

OTHERMoisturizer B, F#E1387-004

Cosmetic Moisturizer. Used twice daily on left or right lower leg per randomization schedule.

PROCEDURERegression

2 week regression period after 6 weeks of moisturizer use.

PROCEDURENon-Regression

Physical insult (tape stripping) on the lower leg after 6 weeks of moisturizer use.

Sponsors

Johnson & Johnson Consumer Inc. (J&JCI)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The test moisturizers were assigned a product code; each moisturizer was assigned to a subject's right or left lower leg per a randomization schedule. Subjects were blinded to the product identities, and evaluators were blinded to which product was used on each leg. Procedural group was unblinded and based on scheduling at Visit 1.

Intervention model description

Subjects were assigned to one of two procedural groups (Regression or Non-Regression) based on Visit 1 scheduling. Subjects were provided with a commercial cleanser to use during a 3-day period with no moisturizers and no hair removal allowed on their lower legs, and to continue using throughout the study. At Visit 2, all subjects received the two test moisturizers to use split-leg (right vs. left lower leg randomized) to use for 6 weeks. Subjects returned for evaluations at Week 2 (Visit 3), Week 4 (Visit 4), and Week 6 (Visit 5). At Week 6, subjects in the Regression group entered a 2-week regression period (no moisturizer usage) and returned for evaluations at Regression Days 1, 4, 7, 10, and 14. Meanwhile, at Week 6, subjects in the Non-Regression group (exploratory) continued using the moisturizers; they returned for evaluations at Week 6 + Days 1, 2, 3, and 4.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* moderately to severely dry skin on both leg legs, as determined by the investigator. * Fitzpatrick skin types I-IV * generally in good health * routinely uses moisturizers on the legs at least 1-3 times per week. * if of reproductive potential: using a medically acceptable form of birth control for at least 3 months before the study and willing to continue it for at least 1 month after study completion. * able to read, write, speak, and understand English. * willing and able to complete all study instructions. * has completed the informed consent document including a HIPAA disclosure and photograph release.

Exclusion criteria

* known allergies/sensitivities to adhesive tapes or study product ingredients. * known skin conditions, uncontrolled medical conditions, or any other condition that could interfere with evaluations/data interpretation or increase risk to the subject. * any active bacterial/fungal/viral skin infections or susceptibility to such infections. * females who are pregnant, breastfeeding, or planning to become pregnant in near future. * compromised/broken skin, tattoos, scarring, excessive hair growth, very uneven skin tone, or other conditions that would interfere with evaluations or increase risk to the subject. * current participation in another study. * participation in another study in past 4 weeks. * employees or relatives of the investigator or study site.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change from Baseline to Week 6 in Clinical Grading of Skin DrynessBaseline to Week 6The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.

Secondary

MeasureTime frameDescription
Mean Change from Baseline to Week 4 in Clinical Grading of Skin DrynessBaseline to Week 4The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin DrynessRegression Baseline to Regression Day 1The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin DrynessRegression Baseline to Regression Day 4The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin DrynessRegression Baseline to Regression Day 7The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Skin DrynessRegression Baseline to Regression Day 10The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Skin DrynessRegression Baseline to Regression Day 14The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Mean Change from Baseline to Week 2 in Clinical Grading of Skin CrackingBaseline to Week 2The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Baseline to Week 4 in Clinical Grading of Skin CrackingBaseline to Week 4The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Baseline to Week 6 in Clinical Grading of Skin CrackingBaseline to Week 6The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin CrackingRegression Baseline to Regression Day 1The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin CrackingRegression Baseline to Regression Day 4The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin CrackingRegression Baseline to Regression Day 7The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Skin CrackingRegression Baseline to Regression Day 10The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Skin CrackingRegression Baseline to Regression Day 14The investigator assessed each of the subject's lower legs for skin cracking on a scale of 0 (none) to 8 (obvious cracking). Whole points only.
Mean Change from Baseline to Week 2 in Clinical Grading of Skin ScalingBaseline to Week 2The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Baseline to Week 4 in Clinical Grading of Skin ScalingBaseline to Week 4The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Baseline to Week 6 in Clinical Grading of Skin ScalingBaseline to Week 6The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin ScalingRegression Baseline to Regression Day 1The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin ScalingRegression Baseline to Regression Day 4The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin ScalingRegression Baseline to Regression Day 7The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Skin ScalingRegression Baseline to Regression Day 10The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Skin ScalingRegression Baseline to Regression Day 14The investigator assessed each of the subject's lower legs for skin scaling on a scale of 0 (none) to 8 (large scales). Whole points only.
Mean Change from Baseline to Week 2 in Clinical Grading of Tactile RoughnessBaseline to Week 2The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Baseline to Week 4 in Clinical Grading of Tactile RoughnessBaseline to Week 4The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Baseline to Week 6 in Clinical Grading of Tactile RoughnessBaseline to Week 6The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Tactile RoughnessRegression Baseline to Regression Day 1The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Tactile RoughnessRegression Baseline to Regression Day 4The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Tactile RoughnessRegression Baseline to Regression Day 7The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Regression Baseline to Regression Day 10 in Clinical Grading of Tactile RoughnessRegression Baseline to Regression Day 10The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Regression Baseline to Regression Day 14 in Clinical Grading of Tactile RoughnessRegression Baseline to Regression Day 14The investigator assessed each of the subject's lower legs for tactile roughness on a scale of 0 (none) to 3 (severe) scale. Half-points allowed.
Mean Change from Baseline to Week 2 in Clinical Tolerance GradingBaseline to Week 2The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Baseline to Week 4 in Clinical Tolerance GradingBaseline to Week 4The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Baseline to Week 6 in Clinical Tolerance GradingBaseline to Week 6The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Regression Baseline to Regression Day 1 in Clinical Tolerance GradingRegression Baseline to Regression Day 1The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Regression Baseline to Regression Day 4 in Clinical Tolerance GradingRegression Baseline to Regression Day 4The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Regression Baseline to Regression Day 7 in Clinical Tolerance GradingRegression Baseline to Regression Day 7The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Regression Baseline to Regression Day 10 in Clinical Tolerance GradingRegression Baseline to Regression Day 10The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Regression Baseline to Regression Day 14 in Clinical Tolerance GradingRegression Baseline to Regression Day 14The investigator assessed each of the subject's lower legs for the following tolerance parameters on a scale of 0 (none) to 3 (severe): * erythema * edema * burning/stinging (via subject interview) * itching (via subject interview) * tightness (via subject interview) Half-points allowed.
Mean Change from Baseline to Week 4 in TEWLBaseline to Week 4Transepidermal water loss (TEWL), a measure of the passive transfer of water through the outer layer of the skin in g/m2/h, was measured with an open-chambered evaporimeter. Three measurements were taken per leg.
Mean Change from Baseline to Week 6 in TEWLBaseline to Week 6Transepidermal water loss (TEWL), a measure of the passive transfer of water through the outer layer of the skin in g/m2/h, was measured with an open-chambered evaporimeter. Three measurements were taken per leg.
Mean Change from Regression Baseline to Regression Day 1 in TEWLRegression Baseline to Regression Day 1Transepidermal water loss (TEWL), a measure of the passive transfer of water through the outer layer of the skin in g/m2/h, was measured with an open-chambered evaporimeter. Three measurements were taken per leg.
Mean Change from Regression Baseline to Regression Day 4 in TEWLRegression Baseline to Regression Day 4Transepidermal water loss (TEWL), a measure of the passive transfer of water through the outer layer of the skin in g/m2/h, was measured with an open-chambered evaporimeter. Three measurements were taken per leg.
Mean Change from Regression Baseline to Regression Day 7 in TEWLRegression Baseline to Regression Day 7Transepidermal water loss (TEWL), a measure of the passive transfer of water through the outer layer of the skin in g/m2/h, was measured with an open-chambered evaporimeter. Three measurements were taken per leg.
Mean Change from Regression Baseline to Regression Day 10 in TEWLRegression Baseline to Regression Day 10Transepidermal water loss (TEWL), a measure of the passive transfer of water through the outer layer of the skin in g/m2/h, was measured with an open-chambered evaporimeter. Three measurements were taken per leg.
Mean Change from Regression Baseline to Regression Day 14 in TEWLRegression Baseline to Regression Day 14Transepidermal water loss (TEWL), a measure of the passive transfer of water through the outer layer of the skin in g/m2/h, was measured with an open-chambered evaporimeter. Three measurements were taken per leg.
Mean Change from Baseline to Week 4 in Skin HydrationBaseline to Week 4Skin hydration of the lower legs was measured with two different instruments: 1) a Corneometer, which measures hydration in arbitrary units from 0 to 120, with higher values indicating more hydrated skin, and 2) Skicon, which measures hydration in microSiemens (uS) from 0 to 2000, with higher values indicating more hydrated skin. Five measurements were taken with each instrument.
Mean Change from Baseline to Week 6 in Skin HydrationBaseline to Week 6Skin hydration of the lower legs was measured with two different instruments: 1) a Corneometer, which measures hydration in arbitrary units from 0 to 120, with higher values indicating more hydrated skin, and 2) Skicon, which measures hydration in microSiemens (uS) from 0 to 2000, with higher values indicating more hydrated skin. Five measurements were taken with each instrument.
Mean Change from Regression Baseline to Regression Day 1 in Skin HydrationRegression Baseline to Regression Day 1Skin hydration of the lower legs was measured with two different instruments: 1) a Corneometer, which measures hydration in arbitrary units from 0 to 120, with higher values indicating more hydrated skin, and 2) Skicon, which measures hydration in microSiemens (uS) from 0 to 2000, with higher values indicating more hydrated skin. Five measurements were taken with each instrument.
Mean Change from Regression Baseline to Regression Day 4 in Skin HydrationRegression Baseline to Regression Day 4Skin hydration of the lower legs was measured with two different instruments: 1) a Corneometer, which measures hydration in arbitrary units from 0 to 120, with higher values indicating more hydrated skin, and 2) Skicon, which measures hydration in microSiemens (uS) from 0 to 2000, with higher values indicating more hydrated skin. Five measurements were taken with each instrument.
Mean Change from Regression Baseline to Regression Day 7 in Skin HydrationRegression Baseline to Regression Day 7Skin hydration of the lower legs was measured with two different instruments: 1) a Corneometer, which measures hydration in arbitrary units from 0 to 120, with higher values indicating more hydrated skin, and 2) Skicon, which measures hydration in microSiemens (uS) from 0 to 2000, with higher values indicating more hydrated skin. Five measurements were taken with each instrument.
Mean Change from Regression Baseline to Regression Day 10 in Skin HydrationRegression Baseline to Regression Day 10Skin hydration of the lower legs was measured with two different instruments: 1) a Corneometer, which measures hydration in arbitrary units from 0 to 120, with higher values indicating more hydrated skin, and 2) Skicon, which measures hydration in microSiemens (uS) from 0 to 2000, with higher values indicating more hydrated skin. Five measurements were taken with each instrument.
Mean Change from Baseline to Week 2 in Clinical Grading of Skin DrynessBaseline to Week 2The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Mean Change from Baseline to Week 4 in Skin Flaking using D-SquamesBaseline to Week 4D-Squame tapes were used to collect skin surface cells. The first tape was placed on a D-Squame storage card. Image analysis was used to calculate the degree of skin flaking.
Mean Change from Baseline to Week 6 in Skin Flaking using D-SquamesBaseline to Week 6D-Squame tapes were used to collect skin surface cells. The first tape was placed on a D-Squame storage card. Image analysis was used to calculate the degree of skin flaking.
Mean Change from Baseline to Week 4 in NMFs using D-SquamesBaseline to Week 4D-Squame tapes were used to collect skin surface cells. The second tape was stored in a scintillation vial and shipped to a designated lab for analysis of natural moisturizing factors (NMFs), components of the skin that help it maintain adequate hydration.
Mean Change from Baseline to Week 6 in NMFs using D-SquamesBaseline to Week 6D-Squame tapes were used to collect skin surface cells. The second tape was stored in a scintillation vial and shipped to a designated lab for analysis of natural moisturizing factors (NMFs), components of the skin that help it maintain adequate hydration.
Mean Change from Baseline to Week 4 in Epidermal LipidsBaseline to Week 4Special adhesive tapes were used to collect and analyze epidermal lipid samples from the skin surface.
Mean Change from Baseline to Week 6 in Epidermal LipidsBaseline to Week 6Special adhesive tapes were used to collect and analyze epidermal lipid samples from the skin surface.
Mean Change from Regression Baseline to Regression Day 14 in Skin HydrationRegression Baseline to Regression Day 14Skin hydration of the lower legs was measured with two different instruments: 1) a Corneometer, which measures hydration in arbitrary units from 0 to 120, with higher values indicating more hydrated skin, and 2) Skicon, which measures hydration in microSiemens (uS) from 0 to 2000, with higher values indicating more hydrated skin. Five measurements were taken with each instrument.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026